The study in the European Respiratory Journal used advanced spatial mapping techniques to compare healthy lung tissues and ...

A therapy using a patient's own proximal basal stem cells shows promise to treat idiopathic pulmonary fibrosis.

Rutgers Health researchers have discovered that networks of misplaced immune cells drive an aggressive lung disease, ...

Researchers have identified networks of misplaced immune cells, particularly plasma cells, driving idiopathic pulmonary fibrosis (IPF), a fatal lung disease. These cells, typically found in bone ...

The first patient has been dosed in the phase 3 TACTI-004 trial evaluating efti with Keytruda and chemotherapy for advanced ...

Report commissioned by govt analysed cost-effectiveness of 2 medicines, comparing them to to chemo in patients with newly ...

Positive preliminary data from the phase 1b/2 trial evaluating Olvi-Vec in small cell lung cancer have been announced.

We all know at this point that high-sugar diets are not good for us. They increase our risk of developing cardiovascular ...

A new discovery from Rutgers Health scientists could lead to better treatments for a deadly lung disease called Idiopathic ...

Researchers have found a potential new way to slow the progression of lung fibrosis and other fibrotic diseases by inhibiting the expression or function of Piezo2, a receptor that senses mechanical ...

Using real world data from 1,600 patients, available ... Mar. 13, 2025 — A discovery about how severe COVID-19 damages lung cells suggests that an existing drug could treat lingering respiratory ...

Johnson & Johnson has produced the most convincing data to date that its combination of Rybrevant and Lazcluze could replace ...